Clinical Trials Browser

Phase 2/3 × Leukemia, Myeloid × Daunorubicin × Clear all

NCT00111345 2012-05-23

Therapy-Optimization Trial for the Treatment of Acute Myeloid Leukemias (AML) in Children and Adolescents

Phase 2/3 Unknown

Other hematologic neoplasm

Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute